CiteFacts · FDA Drug Shortages · FDA source
Bupivacaine Hydrochloride Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Aspiro Pharma Limited | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32) | Available | 07/17/2026 |
| Aspiro Pharma Limited | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34) | Available | 07/17/2026 |
| Aspiro Pharma Limited | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32) | Available | 07/17/2026 |
| Aspiro Pharma Limited | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34) | Available | 07/17/2026 |
| Aspiro Pharma Limited | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32) | Available | 07/17/2026 |
| Aspiro Pharma Limited | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34) | Available | 07/17/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10) | Available | 08/06/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30) | Available | 08/06/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) | Available | 08/06/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10) | Available | 08/06/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30) | Available | 08/06/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) | Available | 08/06/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10) | Available | 08/06/2026 |
| Eugia US LLC | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30) | Available | 08/06/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | Available | 08/04/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01) | Limited Availability | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30) | Available | 08/07/2026 |
| Huons Co., Ltd | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2) | Unavailable | 07/30/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) | Not stated | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) | Limited Availability | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) | Not stated | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) | Limited Availability | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) | Not stated | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) | Limited Availability | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) | Not stated | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) | Limited Availability | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) | Not stated | 05/05/2026 |
| Kindos Pharmaceuticals Co. Ltd. | Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) | Limited Availability | 05/05/2026 |
| ONESOURCE SPECIALTY PTE LTD | Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL (NDC 72266-263-10) | Available | 08/18/2026 |
| Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25) | Available | 07/20/2026 |
Source facts
Grouped generic ingredient: Bupivacaine Hydrochloride Injection · 61 package records · Latest FDA row update: 08/18/2026
Therapeutic categories: Analgesia/Addiction, Anesthesia
Dosage forms: Injection
Routes: EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL, RETROBULBAR, SUBARACHNOID
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.